1. Introduction to Paracetamol & Diclofenac Sodium Tablets IP (BPR):
The Batch Packing Record (BPR) for Paracetamol & Diclofenac Sodium Tablets IP is an essential pharmaceutical document designed to ensure systematic documentation, traceability, quality assurance, and regulatory compliance throughout the packaging process. Each uncoated tablet contains Paracetamol IP 325 mg and Diclofenac Sodium IP 50 mg, a combination of analgesic and anti-inflammatory agents used for managing pain and inflammation. The BPR provides comprehensive instructions and recording formats for packaging activities, including packaging material dispensing, equipment verification, line clearance, machine setup, blister packing, overprinting, carton packing, shipper packing, and finished product reconciliation. Critical packaging parameters, such as sealing temperature, forming temperature, machine speed, leak testing, environmental conditions, and packaging integrity, are monitored to maintain consistent product quality. The document also includes provisions for in-process quality checks, packaging material reconciliation, rejection analysis, destruction records, yield calculation, and final batch verification by authorized personnel. Proper implementation of the BPR supports compliance with Good Manufacturing Practices (GMP), minimizes packaging errors, prevents product mix-ups, and ensures complete batch traceability. This standardized record serves as an important reference for Production, Quality Assurance, and Quality Control personnel, facilitating effective documentation, batch review, product identification, and controlled release of finished pharmaceutical products.
Skip to PDF content2. Flow Diagram for Paracetamol & Diclofenac Sodium Tablets IP (BPR):
The flow diagram for Paracetamol & Diclofenac Sodium Tablets IP (Batch Packing Record) illustrates the systematic sequence of pharmaceutical packaging operations performed under Good Manufacturing Practices (GMP) to ensure product quality, safety, traceability, and regulatory compliance. The packaging process begins with the transfer of inspected tablets from the manufacturing department to the packaging section. Packaging materials, including aluminium blister foil, PVC film, printed cartons, and corrugated shippers, are dispensed and verified against approved specifications.
Before commencing packaging activities, production personnel perform line clearance, equipment cleaning verification, and blister packing machine setup, followed by Quality Assurance checks. During blister packaging, critical process parameters such as sealing temperature, forming temperature, machine speed, and sealing integrity are monitored. In-process quality checks include leak testing, visual inspection, printed information verification, and identification of defective blisters. Approved blister packs are subsequently packed into printed cartons and corrugated shippers according to the specified packing configuration.,
3. Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) for Paracetamol & Diclofenac Sodium Tablets IP (BPR):
The Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) of Paracetamol & Diclofenac Sodium Tablets IP are essential for ensuring consistent product quality, packaging integrity, patient safety, and compliance with Good Manufacturing Practices (GMP). During blister packaging, important CPPs include forming temperature, sealing temperature, machine speed, sealing pressure, and dwell time. These parameters must be controlled within validated limits to maintain blister integrity and prevent packaging defects. Additional controls include tablet count per blister, overprinting accuracy, visual inspection, carton filling, and shipper packing. In-process checks verify blister sealing, leak-test results, correct product identification, and packaging material conformity.
Critical Quality Attributes include tablet appearance, weight variation, content uniformity, dissolution, blister integrity, printed information accuracy, and correct packaging configuration. Tablet-related attributes are established during manufacturing and verified through applicable quality control testing. Packaging quality attributes ensure protection against moisture, contamination, physical damage, and product mix-ups throughout storage and distribution. The Batch Packing Record documents processing conditions, inspection results, rejection analysis, material reconciliation, and finished product yield. Effective monitoring of CPPs and verification of CQAs support regulatory compliance, batch traceability, consistent product performance, and final Quality Assurance review before product release.